190 related articles for article (PubMed ID: 33350884)
21. Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins.
Katsargyris A; Klonaris C; Tsiodras S; Bastounis E; Giannopoulos A; Theocharis S
Vascular; 2011 Dec; 19(6):320-6. PubMed ID: 21903856
[TBL] [Abstract][Full Text] [Related]
22. Alternative intronic polyadenylation generates the interleukin-6 trans-signaling inhibitor sgp130-E10.
Sommer J; Garbers C; Wolf J; Trad A; Moll JM; Sack M; Fischer R; Grötzinger J; Waetzig GH; Floss DM; Scheller J
J Biol Chem; 2014 Aug; 289(32):22140-50. PubMed ID: 24973212
[TBL] [Abstract][Full Text] [Related]
23. Atherosclerotic plaque instability in carotid arteries: miR-200c as a promising biomarker.
Magenta A; Sileno S; D'Agostino M; Persiani F; Beji S; Paolini A; Camilli D; Platone A; Capogrossi MC; Furgiuele S
Clin Sci (Lond); 2018 Nov; 132(22):2423-2436. PubMed ID: 30389857
[TBL] [Abstract][Full Text] [Related]
24. Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain.
Campbell IL; Erta M; Lim SL; Frausto R; May U; Rose-John S; Scheller J; Hidalgo J
J Neurosci; 2014 Feb; 34(7):2503-13. PubMed ID: 24523541
[TBL] [Abstract][Full Text] [Related]
25. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth.
Wang H; Lathia JD; Wu Q; Wang J; Li Z; Heddleston JM; Eyler CE; Elderbroom J; Gallagher J; Schuschu J; MacSwords J; Cao Y; McLendon RE; Wang XF; Hjelmeland AB; Rich JN
Stem Cells; 2009 Oct; 27(10):2393-404. PubMed ID: 19658188
[TBL] [Abstract][Full Text] [Related]
26. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production.
Ahmed S; Marotte H; Kwan K; Ruth JH; Campbell PL; Rabquer BJ; Pakozdi A; Koch AE
Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14692-7. PubMed ID: 18796608
[TBL] [Abstract][Full Text] [Related]
27. Relationship among serum levels of IL-6, sIL-6R, s gp130 and CD126 on T-cell in HIV-1 infected and uninfected men participating in the Los Angeles Multi-Center AIDS Cohort Study.
Aziz N; Shih R; Alexopoulos N; Jamieson BD; Mimiaga MJ; Martinez-Maza O; Detels R
PLoS One; 2023; 18(10):e0290702. PubMed ID: 37812611
[TBL] [Abstract][Full Text] [Related]
28. An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease.
Lemmers A; Gustot T; Durnez A; Evrard S; Moreno C; Quertinmont E; Vercruysse V; Demetter P; Franchimont D; Le Moine O; Geerts A; Devière J
Clin Exp Immunol; 2009 Jun; 156(3):518-27. PubMed ID: 19438606
[TBL] [Abstract][Full Text] [Related]
29. Imaging Intraplaque Inflammation in Carotid Atherosclerosis With 18F-Fluorocholine Positron Emission Tomography-Computed Tomography: Prospective Study on Vulnerable Atheroma With Immunohistochemical Validation.
Vöö S; Kwee RM; Sluimer JC; Schreuder FH; Wierts R; Bauwens M; Heeneman S; Cleutjens JP; van Oostenbrugge RJ; Daemen JW; Daemen MJ; Mottaghy FM; Kooi ME
Circ Cardiovasc Imaging; 2016 May; 9(5):. PubMed ID: 27162131
[TBL] [Abstract][Full Text] [Related]
30. Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses.
Lamertz L; Rummel F; Polz R; Baran P; Hansen S; Waetzig GH; Moll JM; Floss DM; Scheller J
Sci Signal; 2018 Oct; 11(550):. PubMed ID: 30279168
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 and its receptors: a highly regulated and dynamic system.
Wolf J; Rose-John S; Garbers C
Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
[TBL] [Abstract][Full Text] [Related]
32. Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels.
Wonnerth A; Katsaros KM; Krychtiuk KA; Speidl WS; Kaun C; Thaler K; Huber K; Wojta J; Maurer G; Seljeflot I; Arnesen H; Weiss TW
Metabolism; 2014 May; 63(5):647-53. PubMed ID: 24629561
[TBL] [Abstract][Full Text] [Related]
33. Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance.
Zuliani G; Galvani M; Maggio M; Volpato S; Bandinelli S; Corsi AM; Lauretani F; Cherubini A; Guralnik JM; Fellin R; Ferrucci L
Atherosclerosis; 2010 Nov; 213(1):319-24. PubMed ID: 20869059
[TBL] [Abstract][Full Text] [Related]
34. Enhanced TLR4 endothelial cell immunohistochemical expression in symptomatic carotid atherosclerotic plaques.
Katsargyris A; Theocharis SE; Tsiodras S; Giaginis K; Bastounis E; Klonaris C
Expert Opin Ther Targets; 2010 Jan; 14(1):1-10. PubMed ID: 20001205
[TBL] [Abstract][Full Text] [Related]
35. Low Osteopontin N-Terminal Fragment and Carotid Plaque Stability Associated with Statin or Antiplatelet Therapy.
Hamias R; Volvich L; Paran E; Sion-Vardi N; Novack V; Szendro G; Greenberg G; Rudich A; Wolak T
Curr Vasc Pharmacol; 2016; 14(3):288-94. PubMed ID: 26321081
[TBL] [Abstract][Full Text] [Related]
36. Family-based association study of interleukin 6 (IL6) and its receptor (IL6R) functional polymorphisms in schizophrenia in the Polish population.
Kapelski P; Skibinska M; Maciukiewicz M; Pawlak J; Permoda-Osip A; Twarowska-Hauser J
J Neuroimmunol; 2015 Aug; 285():62-7. PubMed ID: 26198920
[TBL] [Abstract][Full Text] [Related]
37. Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does viscum album treatment affect these parameters?
Kovacs E; Kuehn JJ
Biomed Pharmacother; 2002 May; 56(3):152-8. PubMed ID: 12046687
[TBL] [Abstract][Full Text] [Related]
38. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy.
Verhoeven BA; Moll FL; Koekkoek JA; van der Wal AC; de Kleijn DP; de Vries JP; Verheijen JH; Velema E; Busser E; Schoneveld A; Virmani R; Pasterkamp G
Stroke; 2006 Aug; 37(8):2054-60. PubMed ID: 16809559
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the genetic variants associated with circulating levels of sgp130. Results from the IMPROVE study.
Bonomi A; Veglia F; Baldassarre D; Strawbridge RJ; Golabkesh Z; Sennblad B; Leander K; Smit AJ; Giral P; Humphries SE; Tremoli E; Hamsten A; de Faire U; Gigante B;
Genes Immun; 2020 Feb; 21(2):100-108. PubMed ID: 31932740
[TBL] [Abstract][Full Text] [Related]
40. Cadmium exposure as measured in blood in relation to macrophage density in symptomatic atherosclerotic plaques from human carotid artery.
Fagerberg B; Kjelldahl J; Sallsten G; Barregard L; Forsgard N; Österberg K; Hultén LM; Bergström G
Atherosclerosis; 2016 Jun; 249():209-14. PubMed ID: 27156912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
